Literature DB >> 14641062

Fructosamine 3-kinase, an enzyme involved in protein deglycation.

G Delpierre1, E Van Schaftingen.   

Abstract

The in vivo formation of fructosamines following non-enzymatic reaction of proteins with glucose (i.e. glycation) was first described almost 30 years ago. Until recently, the only known fate of fructosamines in mammalian cells was their spontaneous conversion into advanced glycation end products. The identification in human erythrocytes of a new enzyme, fructosamine 3-kinase, disclosed the existence of a so-far unsuspected intracellular metabolism of these compounds. Fructosamine 3-kinase phosphorylates with high affinity both low-molecular-mass and protein-bound fructosamines on the third carbon of their deoxyfructose moiety, leading to the formation of fructosamine 3-phosphates. The latter are unstable and spontaneously decompose into inorganic phosphate and 3-deoxyglucosone, with concomitant regeneration of the unglycated amine. The presence of proteins related to fructosamine 3-kinase in many prokaryotic and eukaryotic genomes suggests that this 'deglycation' process is not restricted to mammals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14641062     DOI: 10.1042/bst0311354

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  10 in total

1.  Reduced fructosamine-3-kinase activity and its mRNA in human distal colorectal carcinoma.

Authors:  M Notarnicola; Maria G Caruso; V Tutino; V Guerra; S Frisullo; D F Altomare; G Misciagna
Journal:  Genes Nutr       Date:  2010-02-03       Impact factor: 5.523

2.  Low red blood cell levels of deglycating enzymes in colorectal cancer patients.

Authors:  Maria Notarnicola; Maria Gabriella Caruso; Valeria Tutino; Vito Guerra; Giovanni Misciagna
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

3.  The Moderately (D)efficient Enzyme: Catalysis-Related Damage In Vivo and Its Repair.

Authors:  Ulschan Bathe; Bryan J Leong; Donald R McCarty; Christopher S Henry; Paul E Abraham; Mark A Wilson; Andrew D Hanson
Journal:  Biochemistry       Date:  2021-11-03       Impact factor: 3.321

4.  Molecular phenotyping of a UK population: defining the human serum metabolome.

Authors:  Warwick B Dunn; Wanchang Lin; David Broadhurst; Paul Begley; Marie Brown; Eva Zelena; Andrew A Vaughan; Antony Halsall; Nadine Harding; Joshua D Knowles; Sue Francis-McIntyre; Andy Tseng; David I Ellis; Steve O'Hagan; Gill Aarons; Boben Benjamin; Stephen Chew-Graham; Carly Moseley; Paula Potter; Catherine L Winder; Catherine Potts; Paula Thornton; Catriona McWhirter; Mohammed Zubair; Martin Pan; Alistair Burns; J Kennedy Cruickshank; Gordon C Jayson; Nitin Purandare; Frederick C W Wu; Joe D Finn; John N Haselden; Andrew W Nicholls; Ian D Wilson; Royston Goodacre; Douglas B Kell
Journal:  Metabolomics       Date:  2014-07-25       Impact factor: 4.290

Review 5.  Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.

Authors:  Sebastian Brings; Thomas Fleming; Marc Freichel; Martina U Muckenthaler; Stephan Herzig; Peter P Nawroth
Journal:  Int J Mol Sci       Date:  2017-05-05       Impact factor: 5.923

6.  Adaptations to High Salt in a Halophilic Protist: Differential Expression and Gene Acquisitions through Duplications and Gene Transfers.

Authors:  Tommy Harding; Andrew J Roger; Alastair G B Simpson
Journal:  Front Microbiol       Date:  2017-05-29       Impact factor: 5.640

7.  Glycation abolishes the cardioprotective effects of albumin during ex vivo ischemia-reperfusion.

Authors:  Rudo F Mapanga; Danzil E Joseph; Marco Saieva; Florence Boyer; Philippe Rondeau; Emmanuel Bourdon; M Faadiel Essop
Journal:  Physiol Rep       Date:  2017-01-26

Review 8.  The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.

Authors:  Parveen Salahuddin; Gulam Rabbani; Rizwan Hasan Khan
Journal:  Cell Mol Biol Lett       Date:  2014-08-20       Impact factor: 5.787

9.  Medical bioremediation of age-related diseases.

Authors:  Jacques M Mathieu; John Schloendorn; Bruce E Rittmann; Pedro Jj Alvarez
Journal:  Microb Cell Fact       Date:  2009-04-09       Impact factor: 5.328

Review 10.  Common Protective Strategies in Neurodegenerative Disease: Focusing on Risk Factors to Target the Cellular Redox System.

Authors:  Patrizia Hrelia; Giulia Sita; Marina Ziche; Emma Ristori; Angela Marino; Marika Cordaro; Raffaella Molteni; Vittoria Spero; Marco Malaguti; Fabiana Morroni; Silvana Hrelia
Journal:  Oxid Med Cell Longev       Date:  2020-08-01       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.